Infectivity of pre-seroconversion donations: An analysis of lookback exercises in the Netherlands, 2000-2006

Vox Sanguinis

Volumn 102, Issue 3, 2012, Pages 193-197

  Lieshout Krikke, R W ^a   van 't Ende, E A ^a   Slot, E ^a   Karomi, S ^a   Kivit, R M H ^a   Zaaijer, H L ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

HBV; HCV; HIV; Lookback; Seroconversion; Window period donation

Indexed keywords

ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; SCREENING; SEROCONVERSION;

BLOOD DONORS; BLOOD-BORNE PATHOGENS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 84858282357     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01537.x     Document Type: Article

References (14)

1. Van der Bij AK, Coutinho RA, Van der Poel CL: Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissibly infections from 1995 through 2003 in the Netherlands. Transfusion 2006; 46:1729-1736
2. Koppelman MH: Viral Safety of Blood Donations, Molecular Detection of Blood Transmittable Viruses, Dissertation. ISBN-13:978-90-6464-134-3, 2006
3. Schüttler CG, Caspari G, Jursch CA, et al.: Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000; 355:41-42
4. Stramer SL, Chambers L, Page PL, et al.: Third reported US case of breakthrough HIV transmission from NAT screened blood. Transfusion 2003; 43(Suppl. 9):40a-41a
5. Official Journal of the Europian Communities, Council Recommendation 1998/463/EC of 29 June 1998
6. Official Journal of the Europian Communities, Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003
7. Official Journal of the Europian Communities, Commission Directive 2005/61/EC of 30 September 2005
8. Vrielink H, Van der Poel CP, Reesink HW, et al.: Look-back study of infectivity of anti-HCV ELISA positive blood-components. Lancet 1995; 345:95-96
9. Kleinman SH, Lelie N, Busch MP: Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49:2454-2489
10. Kleinman S, Marshall D, AuBuchon J, et al.: Survival after transfusion as assessed in a large multistate US cohort. Transfusion 2004; 44:386-390
11. Kamper-Jørgensen M, Ahlgren M, Rostgaard K, et al.: Survival after blood transfusion. Transfusion 2008; 48:2577-2584
12. Byrne L, Brant LJ, Davison K, et al.: Transfusion-transmitted human immunodeficiency virus (HIV) from seroconverting donors is rare in England and Wales: results from HIV lookback, October 1995 through December 2008. Transfusion 2010; 51: 1339-1345
13. Goldman M, Patterson L, Long A: Recent Canadian experience with targeted hepatitis C virus lookback. Transfusion 2006; 46:690-694
14. Weusten JJAM, Drimmelen HAJ, Lelie PN: Mathematic modelling of the risk of HBV, HCV and HIV transmission by window-phase donation not detected by NAT. Transfusion 2002; 42:537-548